Despite the absence of direct experimental evidence, a potential involvement of IL-33 in ICD contributing to the control of tumor growth could be inferred from the activation of the NLR family pyrin domain containing 3 (NLRP3) in dendritic cells (DCs) [7,8]. Here, NLRP3 is linked to neoplasm.